Stem cell transplants may get less risky for lymphoma patients, thanks to preliminary research by Drs. Marcel van den Brink and Michael Sadelain. They found that using CD19 specific CAR-T cells does not increase the risk of graft-versus-host-disease after allogenic hematopoietic stem cell transplants. They are planning a phase 1 trial using these donor-derived CAR-T cells to prevent relapse after bone marrow transplants, scheduled for later this year.
New York Jets safety, Calvin Pryor, took time out of his Christmas Day to visit 19-year-old Aeden Wall at MSK. In the Jets final game of the season Pryor dedicated his performance in the Jets 30-10 victory over the Buffalo Bills to Aeden, tweeting out “That was for you Aeden”. Aeden passed away just two days later after an eight-month battle with rhabdomyosarcoma. Continue reading